Congressional Democrats' intensifying efforts to pay for their healthcare overhaul and provide more relief for consumers are threatening to unravel a White House deal with the pharmaceutical industry and turn one of Washington's most powerful lobbies against the legislation.
White House healthcare accord with drug industry may be going sour
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.